INTRODUCTION {#s1}
============

Telomerase, a ribonucleoprotein complex that maintains telomere length at the ends of chromosomes, regulates cellular immortality and tumorigenesis. Normal cells maintain senescence and protect the ends of chromosomes from recombination and end-to-end fusion by shortening telomeres after every cell devision. The *TERT* gene, which encodes the catalytic subunit of telomerase, is expressed in most aggressive cancer cells but is silenced in non-immortalized cells. Re-activation of *TERT* is observed in multiple cancers, indicating that *TERT* is likely driving increased telomerase activity for these malignant cells. This increased activity enables them to overcome replicative senescence and escape apoptosis, and leads to cell immortality \[[@R1], [@R2]\].

Gastric cancer is a common cancer that is influenced by both genetic and environmental factors. Recent genome-wide association studies (GWAS) have shown that single nucleotide polymorphisms (SNPs) in *TERT* are associated with the risk of multiple cancers. However, few studies in Han Chinese populations have examined the association between *TERT* and the risk for GC. In the current study, we evaluated 3 SNPs in *TERT* associated with GC risk and found a significant association between these SNPS and GC in a Han Chinese population.

RESULTS {#s2}
=======

The Chinese Han patient cohort was from Shaanxi province or nearby regions, and comprised of 302 cases and 300 controls. The characteristics of the study population are summarized in Table [1](#T1){ref-type="table"}. The ages of controls and cases were 58.01 ± 11.267 and 60.42 ± 5.143 years, respectively, and there were no differences in age distributions between groups. Subjects were genotyped for SNPs in *TERT* to determine whether there was a genetic association with GC. All genotype frequencies in controls conformed to Hardy-Weinberg equilibrium (all *p* \> 0.05). Associations between *TERT* genotypes and the risk of gastric cancer are listed in Table [2](#T2){ref-type="table"}. We identified two significant SNPs associated with the risk of GC (rs10069690, *p* = 0.021 and rs2853676, *p* = 0.006). The differences in frequency distributions of alleles between cases and controls were compared by Chi-squared test and three SNPs in the *TERT* gene were associated with GC risk at a 5 % level (rs10069690, *p* = 0.004, \[OR\] = 1.56, 95% \[CI\] = 1.15−2.11; rs2242652, *p* = 0.017, \[OR\] = 1.43, 95%\[CI\] = 1.06−1.91 and rs2853676, *p* = 0.001, \[OR\] = 1.63, 95% \[CI\] = 1.21−2.19).

###### Age and gender

              case             \%       control         \%
  ----------- ---------------- -------- --------------- --------
  Total       300                       503             
  Sex                                                   
  Female      69               22.80%   120             40.00%
  Male        233              77.20%   180             60.00%
  Mean ± SD                                             
  Age         58.01 ± 11.267            60.42 ± 5.143   

###### Allele and genotype distributions of SNPs in TERT and their associations with risk of gastric cancer

  SNP          Sample    Genotype distribution n   *p*[^\#^](#tfn_001){ref-type="table-fn"}   Allele distribution   OR (95% CI)                                *p*[^\#^](#tfn_001){ref-type="table-fn"}   HWE *p*-value                                                                  
  ------------ --------- ------------------------- ------------------------------------------ --------------------- ------------------------------------------ ------------------------------------------ --------------- ------------------- ------------------------------------------ -------
  rs10069690             TT                        TC                                         CC                                                               T                                          C                                                                              
               case      18                        89                                         195                   0.021[\*](#tfn_002){ref-type="table-fn"}   125                                        479             1.56 (1.15--2.11)   0.004[\*](#tfn_002){ref-type="table-fn"}   
               control   8                         69                                         219                                                              85                                         507                                                                            0.347
  rs2242652              AA                        AG                                         GG                                                               A                                          G                                                                              
               case      17                        95                                         190                   0.066                                      129                                        475             1.43 (1.06--1.91)   0.017[\*](#tfn_002){ref-type="table-fn"}   
               control   9                         78                                         213                                                              96                                         504                                                                            0.523
  rs2853677              GG                        GA                                         AA                                                               G                                          A                                                                              
               case      97                        217                                        173                   0.171                                      231                                        373             1.25 (0.99--1.58)   0.066                                      
               control   106                       252                                        144                                                              199                                        401                                                                            0.696
  rs2853676              TT                        TC                                         CC                                                               T                                          C                                                                              
               case      16                        100                                        186                   0.006[\*](#tfn_002){ref-type="table-fn"}   132                                        472             1.63 (1.21--2.19)   0.001[\*](#tfn_002){ref-type="table-fn"}   
               control   7                         74                                         219                                                              88                                         512                                                                            0.817

SNP single nucleotide polymorphism, OR odds ratio, 95% CI 95% confidence interval, HWE Hardy--Weinberg equilibrium.

*P*^\#^ value from were calculated from two-sided Chi-squared test.

*p*\* ≤ 0.05 indicates statistical significance.

Logistic regression analyses revealed that SNPs rs10069690 and rs2853676 were associated with GC risk by both a dominant model (rs10069690, \[OR\] = 1.67; 95% \[CI\] = 1.16−2.4; *p* = 0.006 and rs2853676, \[OR\] = 1.72; 95% \[CI\] = 1.2−2.45; *p* = 0.003) and an additive model (rs10069690, \[OR\] = 1.61; 95% \[CI\] = 1.19−2.18; *p* = 0.002 and rs2853676, \[OR\] = 1.63; 95% \[CI\] = 1.2−2.21; *p* = 0.002; Table [3](#T3){ref-type="table"}). All analyses were adjusted by age and gender, and associations with risk of GC remained significant.

###### Frequency distributions of prominent SNPs and their associations with the risk of gastric cancer

  SNP          Minor allele   MAF     Dominant model   Recessive model     Additive model                                                                                                                
  ------------ -------------- ------- ---------------- ------------------- ------------------------------------------ ------------------- ------------------------------------------ ------------------- ------------------------------------------
  rs10069690   T              0.207   0.144            1.67 (1.16--2.4)    0.006[\*](#tfn_004){ref-type="table-fn"}   2.62 (1.08--6.34)   0.033[\*](#tfn_004){ref-type="table-fn"}   1.61 (1.19--2.18)   0.002[\*](#tfn_004){ref-type="table-fn"}
  rs2242652    A              0.214   0.160            1.49 (1.05--2.12)   0.026[\*](#tfn_004){ref-type="table-fn"}   2.32 (0.98--5.49)   0.054                                      1.47 (1.09--1.97)   0.011
  rs2853677    G              0.382   0.332            1.34 (0.96--1.88)   0.089                                      1.27 (0.76--2.12)   0.356                                      1.24 (0.97--1.59)   0.088
  rs2853676    T              0.219   0.147            1.72 (1.2--2.45)    0.003[\*](#tfn_004){ref-type="table-fn"}   2.26 (0.89--5.73)   0.085                                      1.63 (1.2--2.21)    0.002[\*](#tfn_004){ref-type="table-fn"}

*p*^\#^ values were calculated by unconditional logistic regression.

*p*\* ≤ 0.05 indicates statistical significance.

Haplotype analysis was performed for associations between GC and multiple SNPs. Haplotype "TA" was associated with an increased risk of GC (\[OR\] = 1.346; 95% \[CI\] = 1.013--1.786; *p* = 0.04), while a protective haplotype "CG" was also detected (\[OR\] = 0.65; 95% \[CI\] = 0.4833--0.874; *p* = 0.004) after adjustments for age and gender. The results for the association between the TERT haplotype and the risk of GC are listed in Table [4](#T4){ref-type="table"}. In Figure [1](#F1){ref-type="fig"}, the red squares of the TERT linkage disequilibrium (LD) block exhibited statistically significant linkage between rs10069690 and rs2242652.

###### The haplotypes of two SNPs (rs10069690 and rs2242652) and risk of Gastric cancer (adjusted by age and gender)

  Haplotype   freq(case)   freq(control)   OR      \[95%CI\]          *P*[^\#^](#tfn_005){ref-type="table-fn"}
  ----------- ------------ --------------- ------- ------------------ ------------------------------------------
  TA          0.197        0.139           1.583   \[1.164--2.154\]   0.003
  CA          0.017        0.017           0.813   \[0.329--2.01\]    0.654
  CG          0.777        0.84            0.65    \[0.483--0.874\]   0.004

*P*^\#^ for logistic regression adjusted by age and gender, *P* \< 0.05 indicates statistical significance.

OR: Odds ratio. CI: Confidence interval.

![Linkage disequilibrium plots from Chr5p15.33\
Red squares indicate statistically significant associations between a pair of SNPs, as measured by D\'; darker shades of red indicate a higher D\'.](oncotarget-07-82727-g001){#F1}

DISCUSSION {#s3}
==========

Chromosome 5p15.33, which contains at least two plausible candidate genes, *TERT* and *CLTPM1L*, is a unique cancer susceptibility locus associated with about 10 distinct cancers \[[@R3], [@R4]\]. telomerase consists of a protein with reverse transcriptase activity encoded by *TERT* and an RNA component that serves as a template for the telomere repeat. *TERT* (also known as *TP2, TRT, CMM9*, *and EST2*) is expressed in several cell types, anditsexpression of *TERT* regulates cellular senescence, the result of the progressive shortening of telomeres with each cell division until they reach a critically short length (<http://www.ncbi.nlm.nih.gov/gene/7015>). GC patients havehad shorter telomere lengthslength than healthy people, indicating that short telomere length may be associated with increased GC risk.

*TERT*TERT is crucial in activating most immortal cells and cancer cells \[[@R5]\]. Yoo et al. suggested that telomerase activity is detected in 73% of tumors, including gastric carcinomas and non-neoplastic gastric mucosa, while adjacent normal tissues show no enzyme activity \[[@R6]\]. Du et al. examined the role of genetic variants at 5p15 in the progression of multiple cancers, and in GC they found that TERT controls telomere length to cause genomic instability \[[@R22]\]. More recently, several studies have reported that TERT regulates cell proliferation and metastasis, and that it also has a strong effect on alternative splicing and genetic control of telomere length \[[@R24], [@R25]\]. Telomerase also effects tumor proliferation \[[@R26]\], and Lu et al. demonstrated that re-activation of telomerase activity promoted invasiveness and metastasis \[[@R27]\]. Previous studies have focused on the risk of many cancer types like glioma \[[@R8]\], thyroid \[[@R9]\], melanoma \[[@R10]\], breast \[[@R11]\], ovarian \[[@R12]\], endometrial \[[@R13]\], liver \[[@R14]\] and pancreatic cancer \[[@R15]\], Therefore, we hypothesized that polymorphisms in *TERT* may affect the control of telomere length, resulting in invasion and metastasis of gastric tumors.

We focused on the effects of genetic variants in the Chinese Han population. We tested associations of SNPs in *TERT* with GC risk based on an existing GWAS data \[[@R16]\]. In this case--control study we found that rs10069690, rs2853676, and rs2242652 in the *TERT* gene were associated with an increased risk of GC. TheT allele of rs10069690 in *TERT* was associated with a decreased risk for prostate cancer, and it has also been associated with increasedregulated risks of breast and ovarian cancer \[[@R12]\]. As for SNP rs2853676, the risk was increased in GC patients, confirming previous findings that rs2853676 is associated with increased risk of multiple cancer types \[[@R17]\], including glioma, adenocarcinoma, squamous cell carcinoma, and ovarian cancer \[[@R18], [@R19]\]. The SNP rs2242652 was previously associated with increased breast cancer risk \[[@R12]\], and both rs2853676 and rs2242652 have been associated with the risk of melanoma \[[@R21]\], but we did not find any significant association of rs2242652 with GC in this study. Haplotype analysis suggested that the combination of certain SNPs could increase or decrease the risk of GC. A protective effect was also observed for the haplotype "CG" of the *TERT* gene that was associated with a 35% reduction in the risk of GC in our study.

Importantly *TERT* may be upregulated in cancer-free patients in precursor lesions of GC. There is also evidence that full-length *TERT* mRNA and protein are expressed in normal gastric samples \[[@R30]\]. High *TERT* expression in intestinal metaplasia and gastric ulcers have been found, suggesting that over-expression of *TERT* may act as an early event in gastric carcinogenesis and that detection of *TERT* could be useful as an early stage marker for the diagnosis of GC \[[@R28], [@R29]\]. Although the use of *TERT* and telomerase as GC markers is still controversial, that *TERT* will become a useful marker for the early diagnosis of GC. Further investigationsto determine the expression of *TERT* in GC and normal gastric tissues would be helpful.

Despite the statistical power of the current study, there are several limitations. First, study participants were enrolled from the northwest Chinese Han population but the majority of them lived in Shanxi province and its adjacent areas. Thus, future prospective studies are required to confirm these findings and assess their applicability to other ethnic groups. Second, the sample size was relatively small; thus, sequencing of more samples in additional Chinese Han populations and functional assessment of genetic variants are necessary to further validate our findings.

MATERIALS AND METHODS {#s4}
=====================

Subjects {#s4_1}
--------

The use of human samples in this study was approved by the local Ethics Committees and all participants gave consent for their participation. The cases were GC patients recruited from the Second Department of General Surgery of Shaanxi Province Hospital. All GC patients were diagnosed by expert physicians from the Department of General Surgery based on standard diagnostic criteria. Control subjects were recruited from the health checkup center and all of them visited for an annual health examination. Controls were unrelated, age- and ethnicity-matched healthy individuals who were free of GC at the time of enrollment. At last, 302 GC patients and 300 GC-free controls were recruited among the Chinese Han population.

Demographics and clinical data {#s4_2}
------------------------------

Demographic and detailed personal information were collected by a nurse, including age, sex, ethnicity, residential region, and education status. For GC patients, detailed clinical information was collected through a medical chart review or consultation with treating physicians. At least 5 ml of venous blood was collected from each subject.

SNP selection and genotyping {#s4_3}
----------------------------

All 4 SNPs in the *TERT* gene with minor allele frequencies \> 5% in the HapMap ([http://www.hapmap.org](http://www.hapmap.org/)) Han Chinese population, were associated with GC (rs10069690, rs2242652 and rs2853676). A GoldMag-Mini Purification Kit (GoldMag Co. Ltd. Xian city, China) was performed to extract genomic DNA from whole blood. DNAs were stored at −80°C until analysis. DNA concentrations were measured using a NanoDrop 2000 (Thermo Scientific, Waltham, Massachusetts, USA). Sequenom MassARRAY Assay Design 3.0 software was used to design multiplexed SNP MassEXTEND assay, and SNP genotyping was performed utilizing the Sequenom MassARRAY RS1000 as recommended by the manufacturer. Sequenom Typer 4.0 software was used to perform data management and analyses.

Statistical analysis {#s4_4}
--------------------

We performed statistical analyses by using Microsoft Excel and SPSS 17.0 (SPSS, Chicago, IL, USA). In this study, all two-sided *p* ≤ 0.05 were considered as statistically significant. Each SNP frequency in the control subjects was tested for deviations from Hardy--Weinberg equilibrium (HWE) by Fisher\'s exact test. Odds ratios (ORs) and 95% confidence intervals (CIs) were determined using unconditional logistic regression analysis adjusting for age and gender. Allele frequencies and genotype frequencies for each SNP were compared for cases and controls using the Chi-squared test/Fisher\'s exact test to determine the associations between genotypes and GC risk.

Three genetic models (dominant, recessive, and additive) were accessed using PLINK software (<http://pngu.mgh.harvard.edu/purcell/plink/>) to estimate ORs for SNP main effects. ORs and 95% CIs were calculated by unconditional logistic regression analyses adjusted for age and sex. Haploview software (version 4.2) and SHEsis software (<http://analysis.bio-x.cn/myAnalysis.php>) were used to construct haplotype and genetic associations at significant polymorphism loci and to estimate the pairwise linkage disequilibrium (LD), haplotype construction, and genetic association at polymorphism loci.
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